Parallax Volatility Advisers, L.P. Roivant Sciences Ltd. Transaction History
Parallax Volatility Advisers, L.P.
- $49.8 Billion
- Q4 2024
A detailed history of Parallax Volatility Advisers, L.P. transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Parallax Volatility Advisers, L.P. holds 21,878 shares of ROIV stock, worth $228,406. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,878
Previous 30,029
27.14%
Holding current value
$228,406
Previous $346,000
25.43%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ROIV
# of Institutions
332Shares Held
505MCall Options Held
573KPut Options Held
739K-
Qvt Financial LP New York, NY65.8MShares$687 Million76.3% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X062.1MShares$648 Million6.45% of portfolio
-
Viking Global Investors LP47.8MShares$499 Million1.91% of portfolio
-
Vanguard Group Inc Valley Forge, PA44.1MShares$460 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$369 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.35B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...